Citation: | GUO Anping, JIANG Fen, XU Xiaoli, YOU Qidong, LI Yuyan. Design, synthesis and biological application of affinity-based small molecular probe for Hsp90 endoplasmic reticulum paralogue of Grp94[J]. Journal of China Pharmaceutical University, 2019, 50(2): 161-167. DOI: 10.11665/j.issn.1000-5048.20190205 |
[1] |
Liu F,Sun HP,You QD.Advances in small-molecule inhibitors targeting Hsp90-Cdc37 protein-protein interaction[J].J China Pharm Univ(中国药科大学学报),2015,46(3):272-278.
|
[2] |
Hetz C, Papa FR. The unfolded protein response and cell fate control[J].Mol Cell,2017,69(2):169-181.
|
[3] |
Zheng HC, Takahashi H, Takano Y, et al. Overexpression of GRP78 and GRP94 are markers for aggressive behavior and poor prognosis in gastric carcinomas[J].Hum Pathol,2008,39(7):1042-1049.
|
[4] |
Xu Y,Chen Z,Li X,et al.HSP90B1 overexpression predicts poor prognosis in NSCLC patients[J].Tumour Biol,2016,37(10):14321-14328.
|
[5] |
Staron M,Yang Y,Li Z,et al.Gp96,an endoplasmic reticulum master chaperone for integrins and Toll-like receptors,selectively regulates early T and B lymphopoiesis[J].Blood,2010,115(12):2380-2390.
|
[6] |
Liu B,Staron M,Li Z,et al.Essential roles of grp94 in gut homeostasis via chaperoning canonical Wnt pathway[J].Proc Natl Acad Sci U S A,2013,110(17):6877-6882.
|
[7] |
Wanderling S,Simen BB,Argon Y,et al.Grp94 is essential for mesoderm induction and muscle development because it regulates insulin-like growth factor secretion[J].Mol Biol Cell,2007,18(10):3764-3775.
|
[8] |
Zhang Y,Wu BX,Li Z,et al.GP96 is a GARP chaperone and controls regulatory T cell functions[J].J Clin Invest,2015,125(2):859-869.
|
[9] |
Staron M,Wu S,Li Z,et al.Heat-shock protein gp96/grp94 is an essential chaperone for the platelet glycoprotein Ib-IX-V complex[J].Blood,2011,117(26):7136-7144.
|
[10] |
Patel PD,Yan P,Chiosis G,et al.Paralog-selective Hsp90 inhibitors define tumor-specific regulation of HER2[J].Nat Chem Biol,2013,9(11):677-684.
|
[11] |
Gewirth DT. Paralog specific Hsp90 inhibitors a brief history and a bright future[J].Curr Top Med Chem,2016,16(25):2779-2791.
|
[12] |
Taldone T,Patel PD,Chiosis G,et al.Experimental and structural testing module to analyze paralogue-specificity and affinity in the Hsp90 inhibitors series[J].J Med Chem,2013,56(17):6803-6818.
|
[13] |
Jiang F, Guo AP, You QD, et al. Discovery of a potent Grp94 selective inhibitor with anti-inflammatory efficacy in a mouse model of ulcerative colitis[J].J Med Chem,2018,61(21):9513-9533.
|
[1] | LI Zhiyan, LI Xianghui, AI Shichao, YIN Yi, LIU Song, GUAN Wenxian. Application of nanomedicines targeting non-glucose nutrients in tumor starvation therapy[J]. Journal of China Pharmaceutical University, 2022, 53(4): 392-399. DOI: 10.11665/j.issn.1000-5048.20220402 |
[2] | PAN Xiuhua, WU Zhenghong, QI Xiaole. Research status and application progress of CRISPR/Cas9 delivery system[J]. Journal of China Pharmaceutical University, 2020, 51(1): 10-18. DOI: 10.11665/j.issn.1000-5048.20200102 |
[3] | JI Liyang, HAO Jing, WANG Guocheng, XIE Weijia. Research progress on stimulator of interferon genes agonists for cancer immunotherapy[J]. Journal of China Pharmaceutical University, 2020, 51(1): 1-9. DOI: 10.11665/j.issn.1000-5048.20200101 |
[4] | SUN Xiaofeng, LIU Tao, LING Yun, CHEN Zhengwei, PAN Zihao, XU Zite, LUO Ling. Advances in research of hyaluronic acid modified nanomicelles for targeting tumor therapy and drug release behavior[J]. Journal of China Pharmaceutical University, 2019, 50(6): 641-647. DOI: 10.11665/j.issn.1000-5048.20190602 |
[5] | XU Xiangting, WANG Wei. Advances of functionalized carbon nanotubes in diagnosis and treatment of tumor[J]. Journal of China Pharmaceutical University, 2018, 49(2): 165-172. DOI: 10.11665/j.issn.1000-5048.20180205 |
[6] | CAI Han, LIU Yanhong, YIN Tingjie, ZHOU Jianping, HUO Meirong. Advances in the targeted therapy of tumor-associated fibroblasts[J]. Journal of China Pharmaceutical University, 2018, 49(1): 20-25. DOI: 10.11665/j.issn.1000-5048.20180103 |
[7] | ZHANG Ran, TIAN Hong, GAO Xiangdong, YAO Wenbing. Application of next generation genome editing technology in gene therapy and biopharmaceuticals[J]. Journal of China Pharmaceutical University, 2014, 45(4): 504-510. DOI: 10.11665/j.issn.1000-5048.20140421 |
[8] | JIANG Hulin. Biocompatible polymers for gene delivery in cancer gene therapy[J]. Journal of China Pharmaceutical University, 2013, 44(5): 476-481. DOI: 10.11665/j.issn.1000-5048.20130518 |
[9] | YAO Jing, FAN Ying, ZHOU Jian-ping, LI Fei-yan. Advances on the study of new cationic polymers as gene vectors[J]. Journal of China Pharmaceutical University, 2011, 42(2): 176-181. |
[10] | Pharmacokinetics of Magnetic Nanoparticles as Drug Carrier and Their Applications in Cancer Diagnosis and Therapy[J]. Journal of China Pharmaceutical University, 2003, (3): 85-88. |